INBS

MKT CAP:$2M

Intelligent Bio Solutions Inc.

Market Cap

$2M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$2.93-$4.96 (-62.86%)

Apr 20, 2026

Company Details

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transi...

CEO

Harry Simeonidis

IPO Date

Dec 23, 2020

Website

gbs.inc

Key Metrics TTM

Revenue

$3M

+3.3% YoY

Net Income

-$11M

EPS (Diluted)

-$17.30

Free Cash Flow

-$10M

Revenue / Share

$3.85

Gross Margin

33.9%

Operating Margin

-329.6%

Net Margin

-330.1%

FCF Margin

-317.1%

P/S

0.5x

P/E

—

Earnings Reports

Q2 2026

May 12, 2026

PENDING

Q1 2026

Nov 12, 2025

$1M+27.5%EPS -$3.50

FY 2025

Aug 15, 2025

$3M-1.9%EPS -$20.00

Q4 2025

Aug 15, 2025

$843.9K+15.9%EPS -$4.40

Q3 2025

May 13, 2025

$728.9K-11.5%EPS -$4.40

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$0	$0	-$3M
Q3 22	$0	$0	-$1M
Q4 22	$0	$0	-$2M
Q1 23	$0	$0	-$1M
Q2 23	$356.7K	$244.0K	-$2M
Q3 23	$457.1K	$33.0K	-$7M
Q4 23	$443.1K	-$120.0K	-$3M
Q1 24	$796.1K	$232.3K	-$3M
Q2 24	$764.1K	$199.2K	-$2M
Q3 24	$823.8K	$178.5K	-$3M
Q4 24	$727.8K	$815.6K	-$3M
Q1 25	$872.3K	$346.8K	-$3M
Q2 25	$607.5K	$223.1K	-$2M
Q3 25	$728.9K	$341.4K	-$3M
Q4 25	$843.9K	$335.6K	-$3M
Q1 26	$1M	$214.9K	-$3M

Valuation

Quarter	P/S	P/E
Q2 22	1.0x	—
Q3 22	1.0x	—
Q4 22	—	—
Q1 23	—	—
Q2 23	4.7x	—
Q3 23	2.1x	—
Q4 23	1.3x	—
Q1 24	0.8x	—
Q2 24	0.7x	—
Q3 24	0.6x	—
Q4 24	0.5x	—
Q1 25	0.5x	—
Q2 25	0.6x	—
Q3 25	0.6x	—
Q4 25	0.6x	—
Q1 26	0.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 22	-$1M	-$1M
Q3 22	-$299.1K	-$477.9K
Q4 22	-$2M	-$2M
Q1 23	-$2M	-$2M
Q2 23	-$2M	-$2M
Q3 23	-$3M	-$3M
Q4 23	-$584.3K	-$584.3K
Q1 24	-$1M	-$1M
Q2 24	-$3M	-$3M
Q3 24	-$2M	-$2M
Q4 24	-$3M	-$3M
Q1 25	-$2M	-$2M
Q2 25	-$2M	-$2M
Q3 25	-$3M	-$3M
Q4 25	-$2M	-$2M
Q1 26	-$3M	-$3M

Capital Expenditures

Quarter	CapEx
Q2 22	$0
Q3 22	$178.8K
Q4 22	$203.0K
Q1 23	$474.9K
Q2 23	$29.6K
Q3 23	$678
Q4 23	$0
Q1 24	$3
Q2 24	$56.7K
Q3 24	$2.6K
Q4 24	$167.3K
Q1 25	$0
Q2 25	$8.9K
Q3 25	$14.4K
Q4 25	$208.5K
Q1 26	$70.4K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 22	—	+277.9%
Q3 22	-100.0%	-57.7%
Q4 22	-100.0%	-15.1%
Q1 23	—	-15.4%
Q2 23	—	-28.2%
Q3 23	—	+421.3%
Q4 23	—	+49.5%
Q1 24	—	+172.7%
Q2 24	+114.2%	+10.8%
Q3 24	+80.2%	-46.0%
Q4 24	+64.2%	+13.4%
Q1 25	+9.6%	+8.3%
Q2 25	-20.5%	+4.2%
Q3 25	-11.5%	-13.1%
Q4 25	+15.9%	+11.5%
Q1 26	+27.5%	+12.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 22	$0	—
Q3 22	$0	—
Q4 22	$0	—
Q1 23	$0	—
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$218.3K	26.5%
Q4 24	$12.2K	1.7%
Q1 25	$202.0K	23.2%
Q2 25	$12.0K	2.0%
Q3 25	$12.0K	1.6%
Q4 25	$12.0K	1.4%
Q1 26	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q2 22	$3M	$1M	—	—
Q3 22	$413.3K	$1M	—	—
Q4 22	$692.6K	$1M	—	—
Q1 23	$79.3K	$1M	—	—
Q2 23	$1.2K	$2M	—	—
Q3 23	$299.9K	—	—	$2M
Q4 23	$127.1K	—	—	$2M
Q1 24	$103.9K	$2M	—	—
Q2 24	$348.5K	$2M	—	—
Q3 24	$471.3K	—	—	$2M
Q4 24	$750.1K	—	—	$3M
Q1 25	$948.8K	—	—	$2M
Q2 25	$506.9K	$2M	—	—
Q3 25	$358.4K	—	—	$2M
Q4 25	$1M	$1M	$2M	—
Q1 26	$486.2K	—	—	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$11M	$0	$11M
Q4 22	$11M	$0	$11M
Q1 23	$8M	$46.6K	$8M
Q2 23	$3M	$0	$3M
Q3 23	$3M	$99.1K	$3M
Q4 23	$2M	$0	$2M
Q1 24	$2M	$118.2K	$2M
Q2 24	$1M	$0	$1M
Q3 24	$9M	$0	$9M
Q4 24	$6M	$0	$6M
Q1 25	$6M	$111.2K	$6M
Q2 25	$2M	$0	$2M
Q3 25	$3M	$0	$3M
Q4 25	$1M	$0	$1M
Q1 26	$2M	$0	$2M
Q2 26	$740.4K	$0	$740.4K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	74K	+6.3%	+3.6%
Q3 22	74K	+0.0%	+26.2%
Q4 22	74K	0.0%	+9.6%
Q1 23	74K	0.0%	+6.3%
Q2 23	8K	-89.8%	-89.8%
Q3 23	111K	+1365.2%	+49.0%
Q4 23	101K	-9.4%	+35.0%
Q1 24	195K	+94.4%	+162.5%
Q2 24	95K	-51.4%	+1154.7%
Q3 24	208K	+119.0%	+87.6%
Q4 24	304K	+46.2%	+202.6%
Q1 25	381K	+25.3%	+95.0%
Q2 25	454K	+19.0%	+377.6%
Q3 25	577K	+27.2%	+177.5%
Q4 25	527K	-8.6%	+73.4%
Q1 26	855K	+62.1%	+124.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	$13.0K	34
Q1 24	$23.4K	34
Q2 24	$22.5K	34
Q3 24	$24.2K	34
Q4 24	$19.7K	37
Q1 25	$23.6K	37
Q2 25	$16.4K	37
Q3 25	$19.7K	37
Q4 25	$16.9K	50
Q1 26	$22.2K	50

Revenue / Employee